Goldman Sachs Group »

Atyr Pharma shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Atyr Pharma (LIFE) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $202k 144k 1.41
2021-12-31 $138k 19k 7.45

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Ishares Tr CMN (IWM)
Amazon CMN (AMZN)
Nvidia Corporation CMN (NVDA)
Invesco Qqq Tr CMN (QQQ)
Ishares Tr CMN (IVV)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Meta Platforms CMN (META)
Vanguard Index Fds CMN (VOO)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Atyr Pharma

Federated Investors
Logos Global Management
Alyeska Investment Group
Vanguard Group
Citadel Advisors
Checkpoint Capital
Tang Capital Management
Bank of America Corporation
Two Sigma Advisers
Goldman Sachs Group
Dimensional Fund Advisors
Millennium Management
Squarepoint Ops
GSA Capital Partners
Royal Bank of Canada

View all funds holding Atyr Pharma